Divis lab results q4 2021

Mutual Funds. ET TV. More Menu. Earnings season ends today.

Divi's Labs soars 4. Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix. Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery. Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill. India Inc Q2 review: Earnings breadth deteriorates; margin pressure stark. Q3 earnings: Nirmal Bang reviews Glenmark, Divi's results.

Divis lab results q4 2021

Divi's Labs soars 4. Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix. Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery. Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill. India Inc Q2 review: Earnings breadth deteriorates; margin pressure stark. Q3 earnings: Nirmal Bang reviews Glenmark, Divi's results. Pharma Q3: New launches, generic drug demand to aid growth. Cipla Q1 PAT may dip Claris Lifesciences net profit up pc at Rs 35 cr in Q3. Ranbaxy deal to kick in, Halol overhang on Sun Pharma:Brokerages. Good Q3 but Dr Reddy's still far from sustainable growth: Expert.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. As onthe company has a total of Capitalised -- -- -- divis lab results q4 2021 -- Other Expenses

Choose your reason below and click on the Report button. This will alert our moderators to take action. Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits. Stock analysis. Market Research. Nifty 22, Precious Metal.

The Group considered the uncertainty relating to the COVID pandemic in assessing the recoverability of its inventories, receivables and investments. As the Group is into essential manufacturing service, which is exempt from lockdown restrictions, the pandemic did not have any significant impact in its operations or its supply chain, the company added. A part of the project has been completed and became operational and the rest of the capex will be completed during early part of the next financial year. Milestone Alert! Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed — it's all here, just a click away! Login Now!

Divis lab results q4 2021

Choose your reason below and click on the Report button. This will alert our moderators to take action. Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits. Stock analysis.

Myerone card

Capitalised -- -- -- -- -- Other Expenses Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix. Company witnessed revenue contraction for the first time in last 3 years. Stock Reports Plus New. Live Blog. Divis Labs share price was Rs 3, This will alert our moderators to take action Name Reason for reporting: Foul language Slanderous Inciting hatred against a certain community Others. Yearly Save S Ganapaty, Prof. That's all for Divis Labs recommendations. Join Us On. Share this Comment: Post to Twitter. Forex Forex News.

Pharma company, Divi's Labs registered feeble Q4 earnings. However, Divi's Labs did announce good news for shareholders.

Contact mail divislabs. More Menu. N V Ramana, Dr. Expert Views. Dons of Dalal Street. Mutual Funds. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. Currency Converter. Divi's Labs soars 4. S formulations business saw a revenue growth of Home Election Stocks Stock Liveblog.